You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 83 No. 4, April 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Manifestations of Mouse Favus in Man

F. BLANK, DR. SC. NAT., DR. SC. TECH.; GEORGES LECLERC, M.D.; P. TELNER, M.D.

Arch Dermatol. 1961;83(4):587-597.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

The causative organism of mouse favus, Microsporum quinckeanum (Quincke's {alpha}-Pilz, Achorion quinckeanum), has attracted wide interest since Quincke's publications20-22 on this particular type of dermatomycosis. Although Bodin5 and Bloch4 confirmed Quincke's findings, the dermatophyte, a distinct species, and the manifold clinical manifestations caused by it were not well understood for a long time. There are several reasons for this misapprehension: 1. Favus of mice due to Microsporum quinckeanum is less frequent than human favus due to Trichophyton schönleini. In Europe, where human favus is endemic, Quincke's publications induced several authors7-9,15,18 to search for this dermatophyte. They isolated nothing but T. schönleini from favic lesions. 2. A fungus other than T. schönleini causing the formation of scutula did not fit into the doctrinaire schemes of the dermatologists of the last century. They refused to believe that the clinical entity favus, i.e., the presence of scutula, was . . . [Full Text PDF of this Article]


Author Affiliations

MONTREAL, CANADA

Department of Bacteriology and Immunology, McGill University (Dr. Blank); Hôpital Notre Dame (Dr. Leclerc); Department of Medicine, Subdepartment of Dermatology, Royal Victoria Hospital (Dr. Telner).


Footnotes

Submitted for publication April 30, 1960.

This work was supported by a National Health Grant, Project 604-9-49.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.